Can-Fite BioPharma Ltd. (CANF)
AMEX·Healthcare·Biotechnology
$3.18
+1.03%
Mkt Cap $2.20M
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$5.00
Range $5.00 – $5.00
Implied Upside
+57.1%
Consensus $5.00 vs current $3.18
AMEX·Healthcare·Biotechnology
$3.18
+1.03%
Mkt Cap $2.20M
No recent rating data.
Price Target (3 analysts)
$5.00
Range $5.00 – $5.00
+57.1%
Consensus $5.00 vs current $3.18